Product Introduction:
Tellzy MT 40/25 ER Tablet is a combination of two antihypertensive medications: Telmisartan (40 mg) and Metoprolol Succinate (25 mg, Extended Release). Telmisartan is an angiotensin II receptor blocker (ARB), while Metoprolol is a beta-blocker. Together, they help in lowering blood pressure, reducing the risk of stroke and heart attack.
Uses:
-
Hypertension (high blood pressure)
-
Prevention of heart attack and stroke
-
Management of heart failure (as advised by physician)
-
Cardiovascular risk reduction
Benefit:
-
Dual mechanism of action provides better BP control
-
Protects the heart and blood vessels
-
Once-daily dose improves patient compliance
-
Extended-release formulation ensures sustained effect
Composition:
-
Telmisartan 40 mg
-
Metoprolol Succinate (ER) 25 mg
Side Effects:
-
Dizziness
-
Fatigue
-
Slow heartbeat
-
Cold hands and feet
-
Low blood pressure
Safety Advice:
-
Take with or after food at the same time daily
-
Avoid sudden discontinuation without medical advice
-
Monitor blood pressure and heart rate regularly
-
Not recommended during pregnancy
-
Store in a cool, dry place away from sunlight
